449 results about "Fat pad" patented technology

A biocompatible wound dressing comprised of a pad for insertion substantially into a wound site and a wound drape for sealing enclosure of the foam pad at the wound site. The pad, comprised of a foam or other like material having relatively few open cells in contact with the areas upon which cell growth is to be encouraged so as to avoid unwanted adhesions, but having sufficiently numerous open cells so that drainage and negative pressure therapy may continue unimpaired, is placed in fluid communication with a vacuum source for promotion of fluid drainage, as known in the art. The pad is further comprised of an ultra-low density fused-fibrous ceramic, or a bioabsorbable branched polymer, or cell growth enhancing matrix or scaffolding.

Methods and apparatus are provided for selective denervation of conduction pathways in the heart for the treatment of dysrhythmias, including one or more ablation or electroporation catheters having electrodes for stimulating, targeting, and ablating fat pad tissue and other cardiac tissue to selectively denervate heart tissue.

A foot operable controller for a surgical instrument having a main foot pedal assembly providing either proportional or linear control signals when moved laterally and in a vertical direction. Friction between an operator's foot and the foot pedal is minimized by a foot pad having a rotating heel plate. A neutral zone between left and right control positions of the foot pedal enables the operator to move his foot freely without changing control settings. Vertical displacement of the foot pedal is indicated by a plurality of mechanical detents during both upward and downward travel. Changing detent resistance alerts the operator to the vertical position of the foot pedal, indicating that further vertical displacement will change an instrument control signal corresponding to the new foot pedal position, thus providing sensory feedback to the operator indicating a change in the functional mode when the foot pedal is moved.

A method is provided, including identifying that a subject is at risk of suffering from atrial fibrillation (AF). Responsively to the identifying, a risk of an occurrence of an episode of the AF is reduced by applying an electrical current to a site of the subject selected from the group consisting of: a vagus nerve, a sinoatrial (SA) node fat pad, a pulmonary vein, a carotid artery, a carotid sinus, a coronary sinus, a vena cava vein, a jugular vein, an azygos vein, an innominate vein, and a subclavian vein, and configuring the current to stimulate autonomic nervous tissue in the site. Other embodiments are also described.

Methods and devices are provided for gathering impedance data related to implantable restriction devices. In general, the methods and devices can enable patients, health care providers, and others to use gathered data as a feedback mechanism to non-invasively monitor efficacy of an implantable restriction device in a patient and to identify, modify, and / or prescribe a treatment plan for the patient considering the gathered data. Impedance data can be gathered and analyzed for tissue proximate to the restriction device, e.g., a fat pad between a gastric band and the patient's stomach. Electrodes in contact with the tissue can measure an impedance of the tissue, with the impedance between the electrodes changing as the tissue reduces in size (e.g., as fat cells shrink) and / or changes configuration.

A method is provided, including identifying that a subject is at risk of suffering from atrial fibrillation (AF). Responsively to the identifying, a risk of an occurrence of an episode of the AF is reduced by applying an electrical current to a site of the subject selected from the group consisting of: a vagus nerve, a sinoatrial (SA) node fat pad, a pulmonary vein, a carotid artery, a carotid sinus, a coronary sinus, a vena cava vein, a jugular vein, an azygos vein, an innominate vein, and a subclavian vein, and configuring the current to stimulate autonomic nervous tissue in the site. Other embodiments are also described.

A filtering apparatus fits adjacent to the nostrils and nose of the user and includes a rigid base for retaining a filtering material thereon through which the user may breathe. The filter material takes the form of an open-cell foam, in the form of a pad, which is removably held between retainer members carried on the rigid base. The foam pad includes a peripheral sidewall and defines an open cavity in the thickness thereof. A clamping device included in the base has an upper and lower plate that are joined together by fasteners. A supporting arrangement for facial wearing comprises a pair of elongated ear support members arranged in spaced-apart relationship and joined together to define a pivot or hinge mechanism that is captured beneath the opposing surfaces of the base plates.

A method is provided, including identifying that a subject is at risk of suffering from atrial fibrillation (AF). Responsively to the identifying, a risk of an occurrence of an episode of the AF is reduced by applying an electrical current to a site of the subject selected from the group consisting of: a vagus nerve, a sinoatrial (SA) node fat pad, a pulmonary vein, a carotid artery, a carotid sinus, a coronary sinus, a vena cava vein, a jugular vein, an azygos vein, an innominate vein, and a subclavian vein, and configuring the current to stimulate autonomic nervous tissue in the site. Other embodiments are also described.

A method is provided, including implanting in an atrial wall of a subject, from within an atrium, a first electrode contact in a vicinity of a parasympathetic epicardial fat pad of the subject, and implanting a second electrode contact in a body of the subject outside of a heart and a circulatory system. A current is driven between the first and second electrode contacts, and configured to cause parasympathetic activation of the fat pad. Other embodiments are also described.

An apparatus, system, and method are disclosed for accurate measurement, compilation, and presentation of sprinting and running technique data. In one embodiment, the apparatus, system and method includes a knee pad configured to contain a knee pad sensor, a foot pad configured to contain a foot pad sensor and a main trunk that connects the foot pad and the knee pad. The knee pad sensor and the foot pad sensor sense movement near the sensors and contact to the sensors. Data from the sensors is output to a CPU. In one embodiment, the apparatus, system and method include arm sensors. The arm sensors sense arm movement of a user and report arm movement data to the CPU. In a further embodiment, the apparatus may be configured to contain a harness positioned opposite the main trunk.

An embodiment of the system of this invention comprises a U shaped base member having a pair of front wheel receptacles each in turn comprising a pair of uprights. Two such U shaped members may be interconnected in opposite orientation to form a rectangle such that four bikes can be staggered. A foot pad is included for easy ingress and egress. Support brackets are included to increase the strength and the durability of the versatile bicycle stand. Holes are provided in the base member to snugly receive uprights.

A self-anchoring tissue lifting device for use with facial cosmetic reconstructive surgery includes an implant and a removable foil cover disposed on the implant. The implant includes an elongated mesh strip having a distal end on which is situated a tissue anchoring fleece material. Opposite lateral edges of the mesh material are preferably laser cut during the manufacturing process of the implant to provide a plurality of tissue engaging prickles along the longitudinal length of the implant. For treating the mid face and jowl, a stab incision is made within the hairline of the temple region of the patient and the device is applied from the temporal area to the peak of the ipsilateral cheek to capture the malar fat pad to correct midface abnormalities or the ptotic tissue causing the jowl.

To control cardiac arrhythmias, various conduction-modifying agents include biopolymers, fibroblasts, neurotoxins, and growth factors are introduced either epicardially or endocardially to the fat pads in proximity to the ganglia therein. Any desired technique may be used for injection, including injection from a catheter inserted percutaneously, or direct injection through the epicardial during open heart surgery. Preferably the patient's heart is beating throughout the Injection.

A foot pad has an elastic conical body and at least one elastic rib. The elastic conical body defines a connecting surface and an outer conical surface. The connecting surface defines a hollow portion, and the elastic rib integrally connects to the elastic conical body at a surface of the hollow portion. The outer conical surface has a root portion connecting with an outer edge of the connecting surface. A thickness of the elastic conical body at the root portion of the outer conical surface is greater than a thickness of the elastic conical body at other portions of the outer conical surface. Elasticity of the foot pad is thereby increased so as to enlarge a contact area contacting an outer supporting surface, so that an anti-skid effect is improved and the foot pad is capable of absorbing a deformation of an electronic product.

A MOSFET cell of a semiconductor device includes a polysilicon gate electrode and an n+-source region formed in an upper portion of an n−-drift layer. An interlayer insulating film covers the gate electrode. An Al source electrode extends on the interlayer insulating film. An Al gate pad is connected to the gate electrode. A barrier metal layer that prevents diffusion of aluminum is interposed between the source electrode and the interlayer insulating film, and between the gate pad and the gate electrode.

The invention is in the field of methods for medical treatment. It provides an improved method for repairing damaged cartilage and / or preventing cartilage degeneration in tissue, in particular in a joint by administering a pharmaceutically active agent directly into the fat pad of a joint. The pharmaceutically active agent is preferably selected from the group consisting of agents that stimulate chondrogenic differentiation and / or cartilage matrix synthesis; agents that inhibit osteogenesis and / or hypertrophy, anti-inflammatory agents, agents that inhibit apoptosis of chondrocytes, agents that inhibit senescence of chondrocytes and agents that enhance lubrication of a joint.

A method is provided, including identifying that a subject is at risk of suffering from atrial fibrillation (AF). Responsively to the identifying, a risk of an occurrence of an episode of the AF is reduced by applying an electrical current to a site of the subject selected from the group consisting of: a vagus nerve, a sinoatrial (SA) node fat pad, a pulmonary vein, a carotid artery, a carotid sinus, a coronary sinus, a vena cava vein, a jugular vein, an azygos vein, an innominate vein, and a subclavian vein, and configuring the current to stimulate autonomic nervous tissue in the site. Other embodiments are also described.

A foam pad comprising a surface to which a trim cover can be secured, the surface comprising a channel having a width of up to about 15 mm. Disposed in the channel is one of a male portion or a female portion of a releasably engageable male-female trim cover attachment system. A trim cover having the other of the male or female portion attached thereto may be readily attached to the foam pad. A process and a mold for producing the foam pad are also described. The foam pad is particularly useful as a component of a vehicular seat system (e.g., seat bottom, seat back and the like).

An applicator for an anti-microbial solution includes an aerosol container and an applicator pad assembly having a hollow arm. The hollow arm has a proximal end attached to an aerosol cap and a distal end having a flanged arm plate to receive a foam applicator pad. The aerosol cap is removably attached to the aerosol container. A solution flow control is in communication with the aerosol container for selectively dispensing the anti-microbial solution. The aerosol container holds the anti-microbial solution under pressure and flow is controlled by a pressure-sensitive flow control tab. The control tab activates the flow of the anti-microbial solution from the aerosol container through the hollow handle to the foam pad and then to the patient. The control tab may be actuated by touch or by pressure applied to the applicator pad. An optional flow control feature, in addition to the control tab, is a slit formed in the foam pad. The slit is designed so that it remains closed when no pressure is exerted on the distal surface of the foam pad. However, when pressure is exerted on the distal surface of the foam pad, such as when the applicator is pressed against a patient's skin, the slit opens to allow the anti-microbial solution to flow past the slit into the foam pad. There the anti-microbial solution can be easily distributed over the patient's skin by the foam pad. When a sufficient amount of the anti-microbial solution has flowed into the foam pad, the healthcare professional can release the pressure sensitive control tab to stop the flow of anti-microbial solution out of the aerosol container.

A surgical device for suspending soft tissue in a procedure for elevation of the malar fat pad is constructed from a pair of shafts that are fused to the ends of two sutures, such that both sutures are fused at one end to a common shaft at the proximal end of the shaft, and at their other ends to a second common shaft at its proximal end. The distal ends of both shafts are free for insertion into incisions in the patient, and are blunt-tipped to avoid injuries to nerves or blood vessels. In certain embodiments, one of the sutures, termed the suspension suture, is threaded through an anchor graft, to engage and elevate the malar fat pad, the anchor graft preferably being ring-shaped to allow ingrowth of soft tissue.

A biocompatible wound dressing comprised of a pad for insertion substantially into a wound site and wound drape for sealing enclosure of the foam pad at the wound site. The pad, comprised of a foam or other like material having relatively few open cells in contact with the areas upon which cell growth is to be encouraged so as to avoid unwanted adhesions, but having sufficiently numerous open cells so that drainage and negative pressure therapy may continue unimpaired, is placed in fluid communication with a vacuum source for promotion of fluid drainage, as known in the art. The pad is further comprised of an ultra-low density fused-fibrous ceramic, or a bioabsorbable branched polymer, or cell growth enhancing matrix or scaffolding.

A seat pad is provided with a lower pad member and a upper pad member that is attached to the lower pad member by an adhesive. A pair of projections is formed at the front portion of the seat pad. A concave is defined between the projections. The upper surface of the seat pad is inclined to be lower toward the front end of the seat pad when the seat pad is put on a seat of a chair. When a person sits on the seat pad, a pelvis is held in a proper position, which improves the flow of blood and the behavior of nerve.

A seat pad for a cyclist garment, including a first side, an opposing second side, perforations formed through the seat pad so as to traverse from the first side to the second side and allowing passage of fluid therethrough, and at least one channel defined in the first side connecting together at least two of the perforations and being configured to direct fluid flow when the garment is worn.

An orthotic device is designed to be reused and reapplied in open shoes include an adhesive layer which securely, but temporarily, bonds the insole to a shoe. In some embodiments, the insole both supports and cushions a foot. In other embodiments, the insole solely cushions the foot. The supporting insoles include an arch support and a heel lift. The cushioning insoles include a flat sole pad, a contoured sole pad, a ball of foot pad and a heel spur pad. In some embodiments, a textile covering is included over the insole.

A vehicle seat includes: a seat pad that forms a supporting surface that supports a seated occupant; and a skin that is made of a knitted fabric or a woven fabric and covers the seat pad. The skin has a first region and a second region arranged adjacent to each other on the supporting surface, and the first region is lower in density and thinner than the second region.

A protective foot pad comprises a sheet of protective material having a main body portion in the shape of the ball of a human foot and a locating tab extending from the main body portion for location between the first and second toes of the foot, an adhesive on one surface of the sheet for adhering the sheet to the foot, and a removable release liner covering the adhesive until the pad is to be adhered to the foot. The pad is especially suited for protecting the bare foot of a dancer, who will use the pad by removing the release liner to expose the adhesive, placing the exposed adhesive on the bottom of his or her foot to cover at least a portion of the ball of the foot, with the tab extending between the first and second toes, and bending the locating tab over the skin between the first and second toes. The main body portion can include one or more lateral extensions that adhere to the side of the foot. In one embodiment, the adhesive is a layer of material that is adhesive on both surfaces thereof, one of which has the releasable liner thereon. The other surface of the layer of material is disposed on an adhesive surface of the sheet, which is a non-woven, open-matrix, polyester layer.